“I also consider VIRALEZE™ to be a really interesting product opportunity and its rapid
development and launch is a testament to Starpharma’s capable team. however then the wheels fell off and l sincerely wish to assist in improving our sales, marketing and development skills to bring the SPL7013 platform the commercial recognition it deserves
What he should have said (if in fact they are his words or a statement authored by the PR team that he ticked off) in addition to the above. Here's hoping he becomes a valued board member (valued by shareholders that is)
Ann: Dr Jeff Davies appointed as director and Appendix 3X, page-15
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $38.11K | 389.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20455 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 38876 | 3 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |